Collaborative facilities and Service platforms

The Genopole® campus features 19 technology platforms and technical facilities - most of which are open to the biopark’s scientific and business communities.

This infrastructure has been established thanks to steadfast financial support from Genopole®’s usual partners (the Ministry for Higher Education and Research, Ile-de-France Regional Council, Essonne County Council, the Regional Directorate for Industry, Research and the Environment (DRIRE), the Essonne Chamber of Commerce and Industry, the French Muscular Dystrophy Association, the University of Evry-Val d’Essonne, the CEA, the INSERM and the CNRS), as well as additional contributions from the Ecole Nationale Supérieure des Mines de Paris, Armines and the Paris VI and Paris XIII universities.

The Genopole® Infrastructure team is committed to responding to requests for new facilities and promoting the development, accreditation and operation of existing ones.

17 technology platforms :

A technology platform is defined here as the assembly of equipment and human resources in a single location, with a view to offering the user community access to high-level technological resources. Plateforme Puces ADN végétal



2 national facilities:

  • the DNA and Cell Bank
  • the Plant DNA Microarray Platform

14 technology platforms:

  • the MicroScope platform
  • the EVR@ platform (Virtual Environment and @ugmented Reality)
  • the Imaging & Cytometry Platform
  • the HTS Platform
  • the Mass Spectrometry Platform
  • the Center for Exploration and Experimental Functional Research (CERFE)
  • the Biophotonics Platform
  • the Structural Biology Platform
  • the Cell Sorting Workstation
  • the Cell Irradiator
  • the Transmission Electron Microscopy
  • the Center for Functional Investigation and Experimental Research in Amphibians and Fish (CERFAP)

1 technical facility :

  • the Business Incubator Technical Facility

Five of these platforms have been awarded IBiSA accreditation* (*) by the French government:

  • The DNA Microarray Production Platform (CEA)
  • The Plant DNA Microarray Platform (INRA/CNRS/UEVE)
  • The Genopole® CERFE animal facility
  • The Genoscope MicroScope platform
  • The Genethon DNA and Cell Library

(*)IBiSA accreditation (“Infrastructure in healthcare, biology and agronomy”) replaced the French government’s RIO accreditation in 2007.

Under the terms of the IBiSA charter, the operator of the platform (defined as the assembly of equipment and human resources in a single location, with a view to offering the user community access to high-level technological resources) undertakes to provide access not only to on-site users but also to those based regionally and nationally, regardless of their status (publicly-funded labs, companies, etc.).

Platform accreditation and the specific resources (funding, staff) which are attributed accordingly are conditional on provision of a general specification and, depending on the platform’s theme, a more detailed specification. Each platform has a Scientific Advisory Board (comprising both users and external experts) that defines project priorities, ensures the quality of the services offered and suggests methodological changes and upgrades. The platform must display a formal service offering which specifies the access conditions and tariffs.

The platform must set up a quality management system based on the ISO 9001 v2000 standard. It must ensure its long-term technological performance level by performing methodological research that leads to scientific publications or research exploitation.

Regular support for the acquisition of semi-heavy equipment :

Since 1999, Genopole® has launched an annual call for tenders for the acquisition of semi-heavy equipment which can help provide optimal working conditions for existing research groups or attract and anchor new ones. In parallel, Genopole® assists with the acquisition of additional equipment when justified by the development of new themes, the arrival of new researchers, students and trainees and the establishment of new collaborations.

This operation complements the funding provided by the national research institutes when the latter establish and develop research units on the Evry biopark. In line with the spirit of resource-sharing that prevails at Genopole®, the items of equipment are distributed to and operated by the various research groups but can be accessed by all members of the campus scientific and business communities.

To find out more, consult the online directory of technology platforms and technical facilities.

PDF - 1.9 Mb
Plaquette Infrastructures
Plaquette infrastructures éditée en Juin 2006

[+] Previous page

  • Print
  • Envoyer
Latest News

NYSE Euronext welcomes Novagali on its (...)

Novagali Pharma, a pharmaceutical company (...)

Biosystems 
International raises 
2,1
M€

Biosystems
 International
 (BSI) SAS,
 biotech (...)

Collaboration between Cancer Campus & (...)

Genopole® (Evry) & Cancer Campus® (Villejuif)

Introduction en bourse de Novagali sur NYSE (...)

A la suite de l’enregistrement par l’Autorité (...)

Plan d’accès->en Dowload available documents